Pursuant to Regulation 30 and other applicable Regulations of SEBI (LODR), 2015, Hindustan Biosciences has informed that the Board of Directors of the Company in its meeting held today, on October 31, 2026, approved the Un-Audited Standalone Financial Results of the company for the 2nd Quarter ended on 30th September 2026 along with the Limited Review Report; and resignation of Company secretary and Compliance Officer Took note of and accepted the resignation of Shailendra Vyas, Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company, tendered vide his resignation letter dated 31st October, 2026, with effect from the closing hours of 31st October, 2026, due to his decision to pursue an alternative career opportunity outside the Organisation. The details required under Regulation 30 of SEBI (LODR) Regulations, 2015 read with SEBI Master Circular dated November 11, 2024 are enclosed as Annexure A, and a copy of the resignation letter is enclosed as Annexure B. The meeting commenced at 01:00 PM and concluded at 02:00 PM.
